Neumann, Alexander http://orcid.org/0000-0001-6653-3203
Küçükali, Fahri http://orcid.org/0000-0002-3835-9639
Bos, Isabelle
Vos, Stephanie J. B.
Engelborghs, Sebastiaan http://orcid.org/0000-0003-0304-9785
De Pooter, Tim
Joris, Geert
De Rijk, Peter
De Roeck, Ellen
Tsolaki, Magda http://orcid.org/0000-0002-2072-8010
Verhey, Frans
Martinez-Lage, Pablo
Tainta, Mikel
Frisoni, Giovanni http://orcid.org/0000-0001-7075-7082
Blin, Oliver
Richardson, Jill
Bordet, Régis
Scheltens, Philip http://orcid.org/0000-0002-1046-6408
Popp, Julius
Peyratout, Gwendoline
Johannsen, Peter
Frölich, Lutz http://orcid.org/0000-0003-1494-0813
Vandenberghe, Rik
Freund-Levi, Yvonne http://orcid.org/0000-0001-6863-6679
Streffer, Johannes
Lovestone, Simon
Legido-Quigley, Cristina
ten Kate, Mara
Barkhof, Frederik
Strazisar, Mojca
Zetterberg, Henrik http://orcid.org/0000-0003-3930-4354
Bertram, Lars http://orcid.org/0000-0002-0108-124X
Visser, Pieter Jelle
van Broeckhoven, Christine http://orcid.org/0000-0003-0183-7665
Sleegers, Kristel http://orcid.org/0000-0002-0283-2332
Neumann, Alexander
Küçükali, Fahri
Bos, Isabelle
Vos, Stephanie J. B.
Engelborghs, Sebastiaan
De Roeck, Ellen
Tsolaki, Magda
Verhey, Frans
Martinez-Lage, Pablo
Tainta, Mikel
Frisoni, Giovanni
Blin, Oliver
Richardson, Jill
Bordet, Régis
Scheltens, Philip
Popp, Julius
Peyratout, Gwendoline
Johannsen, Peter
Frölich, Lutz
Vandenberghe, Rik
Freund-Levi, Yvonne
Streffer, Johannes
Lovestone, Simon
Legido-Quigley, Cristina
ten Kate, Mara
Barkhof, Frederik
Zetterberg, Henrik
Bertram, Lars
Visser, Pieter Jelle
van Broeckhoven, Christine
Sleegers, Kristel
,
Article History
Received: 12 July 2021
Revised: 4 November 2021
Accepted: 5 January 2022
First Online: 16 February 2022
Competing interests
: FB is on the editorial board of Neurology, Radiology, MSJ, and Neuroradiology, for the latter receiving compensation, personal fees from Springer, personal fees from Biogen, grants from Roche, grants from Merck, grants from Biogen, personal fees from IXICO Ltd, grants from IMI-EU, grants from GE Healthcare, grants from UK MS Society, grants from Dutch Foundation MS Research, grants from NWO, grants from NIHR, personal fees from Combinostics, outside the submitted work; HZ has served at scientific advisory boards for Alector, Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies, and CogRx, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. SL is currently an employee of Janssen Medical Ltd (UK), a cofounder of Akrivia Health Ltd (UK) and within the past 5 years has filed patents related to biomarkers unrelated to the current work and advised or given lectures for Merck, Optum Labs and Eisai as well as having received grant funding from multiple companies as part of EU IMI programs and from Astra Zeneca. JP received consultation honoraria from Nestle Institute of Health Sciences, Ono Pharma, OM Pharma, and Fujirebio, unrelated to the submitted work. SE has served on scientific advisory boards for Biogen, Danone, icometrix, Novartis, Nutricia, Roche and received unrestricted research grants from Janssen Pharmaceutica and ADx Neurosciences (paid to institution). The others authors declare that there is no conflict of interest.